Biomarkers · 2013 · 33 citations · 21 references
MedicineGeneticsOncologyGynecologic OncologyMolecular DiagnosticsMolecular OncologyCancer BiomarkersCirculating Tumor CellsMalignant NeoplasmsOvarian CancerTumor AntigensTumor MarkersCirculating Tumor BiomarkersCirculating Tumor Cell BiomarkersCirculating Tumor MarkersMage AntigensMelanoma-associated AntigensOvarian Cancer BiomarkersOvarian Cancer Prognostic BiomarkersOvarian Tumor Biomarkers
Ovarian cancer is a leading cause of death among gynecologic malignancies. In this study, we reported the expression of melanoma-associated antigens A (MAGE-A) genes in peripheral blood from 80 patients with ovarian cancer and 30 healthy donors. MAGE-As expression was associated with the factors indicating poor prognosis. The expressions of MAGE-As and each individual MAGE-A genes were also associated with low overall survival of patients with ovarian cancer. Our results suggested MAGE-A genes may have the potential to be surveillance markers for the detection of circulating tumor cells and represent a poor prognosis for patients with ovarian cancer.
21
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
Pierre van der Bruggen, Catia Traversari, Patrick Chomez et al. · Science · 1991 · 3.5K citations
Life Sciences, Immunology, Oncology +17
Ahmedin Jemal, Thomas S. Murray, Alicia Samuels et al. · CA A Cancer Journal for Clinicians · 2003 · 3.3K citations · Full text
Medicine, Demography, Oncology +17
Tribute to Patrick Steptoe: beginnings of laparoscopy
R. G. Edwards · Human Reproduction · 1989 · 559 citations
Medicine, Gynecology, Surgery +5
Expression of <i>MAGE</i> genes in primary and metastatic cutaneous melanoma
Francis Brasseur, Donata Rimoldi, Danielle Líénard et al. · International Journal of Cancer · 1995 · 285 citations
Medicine, Dermatology, Oncology +15